Literature DB >> 15942433

Probiotics for the developing world.

Gregor Reid1, Sanjeev Anand, Max O Bingham, Gabriel Mbugua, Torkel Wadstrom, Roy Fuller, Kingsley Anukam, Melanie Katsivo.   

Abstract

Every minute of every day more and more children die of diarrheal diseases and women, and girls become infected by HIV. An estimated 7,000 women become infected each day. While many valiant efforts are being made to address these issues, until now they have proved to be markedly ineffective. The notion that lactic acid bacteria, formulated into food or dietary supplements, could have a role to play in slowing the morbidity and mortality associated with HIV/AIDS and gastroenteritis, is built upon sound clinical findings and scientific investigations, yet no international efforts have been placed in this approach, to date. We hereby summarize the reasons why such efforts should be made, provide an example of one model being set up in sub-Saharan Africa, and challenge the international community to consider the potential benefits of probiotics, especially for communities not reached by governmental and nongovernmental agencies.

Entities:  

Mesh:

Year:  2005        PMID: 15942433     DOI: 10.1097/01.mcg.0000165648.32371.38

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

1.  Evaluating the Probiotic Potential of Lactobacillus plantarum Strains from Algerian Infant Feces: Towards the Design of Probiotic Starter Cultures Tailored for Developing Countries.

Authors:  Chahira Gheziel; Pasquale Russo; Mattia Pia Arena; Giuseppe Spano; Hadda-Imene Ouzari; Omar Kheroua; Djamel Saidi; Daniela Fiocco; Hanane Kaddouri; Vittorio Capozzi
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

2.  Anti-inflammatory effect of bioflora probiotic administered orally or subcutaneously with live or dead bacteria.

Authors:  Om Laudanno; L Vasconcelos; J Catalana; Ja Cesolari
Journal:  Dig Dis Sci       Date:  2006-11-02       Impact factor: 3.487

3.  Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection.

Authors:  Susanna Cunningham-Rundles; Siv Ahrné; Rosemary Johann-Liang; Rachel Abuav; Ann-Margaret Dunn-Navarra; Claudia Grassey; Stig Bengmark; Joseph S Cervia
Journal:  Nutrients       Date:  2011-12-19       Impact factor: 5.717

4.  Inhibition of pathogenic and spoilage bacteria by a novel biofilm-forming Lactobacillus isolate: a potential host for the expression of heterologous proteins.

Authors:  Tannaz Jalilsood; Ali Baradaran; Adelene Ai-Lian Song; Hooi Ling Foo; Shuhaimi Mustafa; Wan Zuhainis Saad; Khatijah Yusoff; Raha Abdul Rahim
Journal:  Microb Cell Fact       Date:  2015-07-07       Impact factor: 5.328

Review 5.  Probiotics in Human Immunodeficiency Virus Infection: A Systematic Review and Evidence Synthesis of Benefits and Risks.

Authors:  George M Carter; Aryan Esmaeili; Hardikkumar Shah; Debbie Indyk; Matthew Johnson; Michael Andreae; Henry S Sacks
Journal:  Open Forum Infect Dis       Date:  2016-07-29       Impact factor: 3.835

6.  Harnessing microbiome and probiotic research in sub-Saharan Africa: recommendations from an African workshop.

Authors:  Gregor Reid; Nicholas Nduti; Wilbert Sybesma; Remco Kort; Tobias R Kollmann; Rod Adam; Hamadi Boga; Eric M Brown; Alexandra Einerhand; Hani El-Nezami; Gregory B Gloor; Irene I Kavere; Johanna Lindahl; Amee Manges; Wondu Mamo; Rocio Martin; Amy McMillan; Jael Obiero; Pamela A Ochieng'; Arnold Onyango; Stephen Rulisa; Eeva Salminen; Seppo Salminen; Antony Sije; Jonathan R Swann; William van Treuren; Daniel Waweru; Steve J Kemp
Journal:  Microbiome       Date:  2014-04-16       Impact factor: 14.650

7.  Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial.

Authors:  Yana Emmy Hoy-Schulz; Kaniz Jannat; Thomas Roberts; Saira Husain Zaidi; Leanne Unicomb; Stephen Luby; Julie Parsonnet
Journal:  BMC Complement Altern Med       Date:  2016-02-02       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.